Evidence map›Paper›PMID 39330682›Full record

ArticleNanomaterials (Basel, Switzerland)2024

Green Synthesis of Metal Nanoparticles with Borojó (

Erika Murgueitio Herrera, Gissela Jacome, Carina Stael, Geovanna Arroyo, Andrés Izquierdo, Alexis Debut, Patricio Delgado, Gemma Montalvo

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Erika Murgueitio HerreraCentro de Nanociencia y Nanotecnología, Universidad de las Fuerzas Armadas ESPE, Av. Gral. Rumiñahui s/n, Sangolqui P.O. Box 171-5-231B, Ecuador.ORCID 0000-0002-1222-3485
Gissela JacomeDepartamento de Ciencias de la Tierra y de la Construcción, Universidad de las Fuerzas Armadas ESPE, Av. Gral. Rumiñahui s/n, Sangolqui P.O. Box 171-5-231B, Ecuador.
Carina StaelCentro de Nanociencia y Nanotecnología, Universidad de las Fuerzas Armadas ESPE, Av. Gral. Rumiñahui s/n, Sangolqui P.O. Box 171-5-231B, Ecuador.
Geovanna ArroyoCentro de Nanociencia y Nanotecnología, Universidad de las Fuerzas Armadas ESPE, Av. Gral. Rumiñahui s/n, Sangolqui P.O. Box 171-5-231B, Ecuador.ORCID 0000-0003-4452-524X
Andrés IzquierdoCentro de Nanociencia y Nanotecnología, Universidad de las Fuerzas Armadas ESPE, Av. Gral. Rumiñahui s/n, Sangolqui P.O. Box 171-5-231B, Ecuador.ORCID 0000-0001-9877-8846
Alexis DebutCentro de Nanociencia y Nanotecnología, Universidad de las Fuerzas Armadas ESPE, Av. Gral. Rumiñahui s/n, Sangolqui P.O. Box 171-5-231B, Ecuador.ORCID 0000-0002-8269-7619
Patricio DelgadoCentro de Nanociencia y Nanotecnología, Universidad de las Fuerzas Armadas ESPE, Av. Gral. Rumiñahui s/n, Sangolqui P.O. Box 171-5-231B, Ecuador.
Gemma MontalvoDepartamento de Química Analítica, Química Física e Ingeniería Química, Universidad de Alcalá, Ctra. Madrid-Barcelona km 33.6, 28871 Alcalá de Henares, Madrid, Spain.ORCID 0000-0002-5640-8908

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The predominant aim of the current research was to generate a proposal for the removal of arsenic, a highly toxic pollutant, encountered within the Papallacta Lagoon in Ecuador. The average concentrations of As yielded ranges between 18 to 652 μg/L, through the use of metallic nanoparticles. Sampling was performed in the lagoon with their respective geographic locations and "in situ" parameters. Nanoparticles of Mn

Indexed as

arsenicborojó (Borojoa patinoi)nanoparticlesPapallacta Lagoon

Identifiers

PMID39330682
PMCPMC11434951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.